Augmenix Receives $6,000,000 Series E Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    204 2nd Avenue Lower Level Waltham, MA 02451 USA
  • Company Description
    Augmenix’s hydrogel technology improves outcomes in prostate radiation oncology and surgery. Learn more about the SpaceOAR system.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series E
  • Proceeds Purposes
    This infusion of capital will allow Augmenix to focus on next-generation products and build on significant growth driven by the robust commercial uptake of its innovative SpaceOAR System.
  • M&A Terms
  • Venture Investor

Trending on Xconomy